Top compounds associated with response to LMLN


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.1
mRNA PX-12 CTRPv2 pan-cancer AAC -0.043 0.1
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC 0.077 0.1
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.053 0.1
mRNA TGX221 GDSC1000 pan-cancer AAC 0.074 0.1
mRNA MG-132 CTRPv2 pan-cancer AAC 0.093 0.1
mRNA lapatinib gCSI pan-cancer AAC -0.078 0.2
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.052 0.2
mRNA GDC-0941 GDSC1000 pan-cancer AAC -0.048 0.2
Download CSV